Sherpa Clinical Packaging has commenced the construction of a new facility adjacent to its 38,000 ft2 headquarters building in San Diego, in a bid to provide better services for the customers.
The new 24,000 ft2 facility is being developed to provide packaging, labeling, and distribution services, helping to meet the requirements of later stage projects and global studies.
Sherpa’s new facility will feature four packaging suites, class 100,000 cleanroom, as well as different temperature-controlled storage areas such as 2-8°C and -20°C rooms and controlled room temperature warehouse.
The construction on the facility is expected to complete by July next year.
Sherpa is also planning to expand operations, quality, and project management teams within the next year, in addition to facilities expansion.
Sherpa president and founder Mark Paiz said: "I am extremely pleased to see so many of our customers moving into Phase II and III clinical trials.
“As the number of global clinical trials that Sherpa supports increases over the next few years, Sherpa's expanded clinical supply offerings, partnerships and facilities are well poised to support this growth."
In February 2016, Sherpa completed a 37,500 ft2 clinical packaging and distribution facility in San Diego.
Featuring cold chain management infrastructure, the new facility provides purpose built space for primary and secondary clinical labeling and packaging.
Sherpa provides clinical trial material management services for clinical studies phases I-IV, including packaging, labeling, distribution and returns/reconciliation, for pharmaceutical, biotechnology, medical device and dietary supplement companies.
